Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Time-Caps is a Japanese biotechnology company specializing in chronotherapy and advanced drug delivery systems. The company's core technology, the Time-Controlled Release System (TCRS) or Time-Capsule, is designed to release medications at precise, pre-programmed times to align with the body's circadian rhythms. This approach is particularly effective for treating conditions like asthma, hypertension, and rheumatoid arthritis, where symptoms often peak at specific times of the day, such as the early morning. By optimizing the timing of drug release, Time-Caps aims to improve therapeutic efficacy, enhance patient compliance, and reduce potential side effects. The company focuses on the reformulation of existing pharmaceutical agents into chronotherapeutic versions using its proprietary capsule technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Time-Caps.